Clementia initiates phase III study of palovarotene for fibrodysplasia ossificans progressive Dec. 7, 2017
La Jolla Pharmaceutical initiates pivotal study of LJPC-401 in patients with beta thalassemia Dec. 5, 2017
FDA grants fast track to Armagen's AGT-181 for the treatment of patients with Hurler syndrome Dec. 1, 2017
RSS